Unlock instant, AI-driven research and patent intelligence for your innovation.

Preparation method of posaconazole

A technology for posaconazole and a purification method, which is applied in the field of preparation of posaconazole, can solve the problems of many by-products, complicated operation, low total yield and the like, and achieves few reaction by-products, simple and safe operation, and no heavy metals. residual effect

Inactive Publication Date: 2017-05-31
SHANGHAI BOCIMED PHARMA CO LTD
View PDF7 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] The technical problem to be solved by the present invention is in order to overcome the complex operation of the preparation method of posaconazole in the prior art, many reaction steps, many by-products, low conversion rate, low total yield, poor product purity and production cost. High, unsuitable for industrialized production and other defects and provide a kind of preparation method of posaconazole

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of posaconazole
  • Preparation method of posaconazole
  • Preparation method of posaconazole

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] Example 1: Preparation of phenyl(4-(4-(4-hydroxy)-1-piperazinyl)phenyl)carbamate (V)

[0029]

[0030] Add 4.00 kg of 1-(4-aminophenyl)-4-(4-hydroxyphenyl)piperazine (VII) and 35.57 kg of tetrahydrofuran into a 100L glass reactor, turn on the stirring, and lower the temperature to 0-10°C. Keep the temperature below 25°C and add 2.56kg of phenyl chloroformate (VIII) dropwise. After 0.5 to 1 hour, the dropping is completed, and the temperature is controlled at 20 to 25°C to continue the reaction for 0.5 to 1.0 hour. The reaction was monitored by TLC. After the reaction was completed, the temperature was lowered to 0-10°C, a saturated aqueous sodium bicarbonate solution (2.00 kg of sodium bicarbonate dissolved in 38 kg of purified water) was added, and 20 kg of purified water was added, followed by stirring for 10 to 20 minutes. Centrifugal filter until almost no solvent flows out, then rinse with 8kg purified water, and centrifuge to filter until almost no solvent flows out....

Embodiment 2

[0032] Example 2: 2-((2S,3S)-2-(benzyl)-3-pentyl)-4-(4-(4-(4-hydroxy)-1-piperazine)phenyl)-2 , 4-Dihydro-3-hydro-1,2,4-triazol-3-one (III) preparation

[0033]

[0034] Add 4.36kg of N'-((2S,3S)-2-benzyloxy)pentyl-3-carboxhydrazine oxalate (VI) and 45.36kg of dioxane into a 100L glass reactor, turn on the stirring, Add 3.45 kg of N,N-diisopropylethylamine. After stirring for 1 to 1.5 hours, 5.47 kg of phenyl(4-(4-(4-hydroxy)-1-piperazinyl)phenyl)carbamate (V) is added. After the addition is completed, the temperature is raised to 80±5°C and reacted for 24-30 hours. TLC monitoring. After the reaction is completed, the system is cooled to 15-25°C, 57.79kg of dichloromethane and 21.81kg of pure water are added, stirred for 10-20 minutes, allowed to stand for separation, collect the lower organic phase, and discard the aqueous phase. The organic phase was transferred to a 100L glass reactor, 21.81 kg of purified water was added to the reactor, stirred for 10-20 minutes, allowed t...

Embodiment 3

[0035] Example 3: 4-(4-(4-(4-(((3R,5R)-5-((1-hydrogen-1,2,4-l-1-triazolyl)methyl)-5 -(2,4-Difluorophenyl)-3-tetrahydrofuranyl)methoxy)phenyl)-1-piperazinyl)phenyl)-2-((2S,3S)-2-(benzyl) -3-pentyl)-2,4-dihydro-3-hydro-1,2,4-triazol-3-one (II) preparation

[0036]

[0037] 35.01kg of dimethyl sulfoxide, with a mass concentration of 50% sodium hydroxide aqueous solution (1.24kg of sodium hydroxide dissolved in 1.24kg of pure water, the mass concentration means that the mass of sodium hydroxide accounts for the total mass of sodium hydroxide aqueous solution %), add to a 50L glass reactor, stir to clear, then add 5.31kg compound (III), stir for 20-30 minutes, add 4.60Kg (3S, 5R)-toluene-4-sulfonic acid 5-(2, 4-Difluorophenyl)-5-(1H-1,2,4-triazol-1-yl)methyltetrahydrofuran-3-ylmethyl ester (IV). After the addition is completed, the temperature is controlled at 25±5°C to react for 8-12 hours. TLC monitors the reaction, after the reaction is complete. Control the temperature to 20-3...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a preparation method of posaconazole. The preparation method of the posaconazole provided by the invention comprises the following steps: in the presence of inorganic protonic acid, performing hydrolysis reaction on a compound II to obtain posaconazole I. The preparation method provided by the invention is easy and safe to operate, does not need any special equipment, is free from heavy metal residues, produces less reaction side products, and has high yield; a prepared product has high purity (chiral purity is larger than 99.90 percent, related substance purity is larger than 99.50 percent, all impurities are less than 0.1 percent, and raw materials meet the standard), is low in production cost, is environmentally friendly, and is suitable for industrial production. The formula of the posaconazole is shown in the description.

Description

Technical field [0001] The invention relates to a preparation method of posaconazole. Background technique [0002] Posaconazole (CAS number: 171228-49-2; chemical name: 4-[4-[4-[4-[[(3R,5R)-5-(2,4-difluorophenyl) -5-(1,2,4-Triazol-1-ylmethyl)oxolane-3-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-2-[( 2S,3S)-2-hydroxypentyl-3-yl]-1,2,4-triazol-3-one) is a triazole antifungal drug with the structure shown in formula I: [0003] [0004] Posaconazole (trade name Noxafil) is a third-generation antifungal drug developed by Schering-Plough Pharmaceutical Co., Ltd. It was first launched in Germany in December 2005, and launched in the United Kingdom in March 2006 until September 18, 2006 Obtained FDA approval. Posaconazole has a wide range of antibacterial properties. It is effective for fungal infections caused by Candida species, Mucorspecies, Aspergillus species, Seedosponum species or Saccharomyces species. Including fluconazole-resistant Cryptococcus neoformans and Histoplasma caps...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D405/14
CPCC07D405/14
Inventor 应述欢皮红军刘振峰陈健乔岩河
Owner SHANGHAI BOCIMED PHARMA CO LTD